Akero Therapeutics Inc (AKRO)

20.43 +0.25  +1.24% NASDAQ Dec 2, 16:00 20.40 -0.02  -0.12% After-Hours: 20:00 USD

Akero Therapeutics EV to EBITDA

View 4,000+ financial data types
Browse...

Historical EV to EBITDA Data

View and export this data going back to 1962. Start your Free Trial
Export Data Date Range:
Data for this Date Range  

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

View EV to EBITDA for AKRO

Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
Start your free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

Advertisement

EV / EBITDA Definition

The EV to EBITDA measures the ratio between enterprise value and earnings before interest, taxes, depreciation, and amortization. This metric is important to analyze when looking at a company's true value based on how much they are valued at compared to how money they are earning.

Read full definition.

EV to EBITDA Related Metrics

EV to Free Cash Flow Upgrade

News

Insider Sell: Akero Therapeutics
MT Newswires 11/05 16:58 ET
Insider Sell: Akero Therapeutics
MT Newswires 11/03 17:56 ET
MIME, LBTYA and PTEN among after hour movers
SA Breaking News 10/19 17:43 ET
Insider Sell: Akero Therapeutics
MT Newswires 10/18 17:05 ET
Insider Sell: Akero Therapeutics
MT Newswires 10/05 16:42 ET
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.